Zusammenfassung
Die 1906 von Alois Alzheimer bei einer nach 4 l/2jährigen Krankheitsdauer verstorbenen 55 jährigen Demenzpatientin klinisch und morphologisch beschriebene und nach ihm benannte Krankheit gilt heute als eines der größten medizinischen und gesundheitspolitischen Probleme der zivilisierten Welt. Sie ist die häufigste Ursache von Demenzen im höheren Lebensalter: in Autopsieserien stellt sie 45–80% neben oder in Verbindung mit vaskulärer Demenz (je 10–20%) bzw. anderen Prozessen in 10–15% [22]. Die praktische Bedeutung der Alzheimer-Krankheit (AD) zeigen die allein in USA für die institutionelle Behandlung von AD-Patienten geschätzten Kosten von 25 Mrd. Dollar pro Jahr [26] und die von der US-Regierung für die Fiskaljahre 1988-90 für AD-Forschung genehmigten Mittel in Höhe von 1,157 Mrd. Dollar (US CARE Act HR 3130-87). Trotz einer wohl nur von der AIDS-Forschung übertroffenen wissenschaftlichen Aktivität sind Ursachen, spezifische Laborbefunde (Marker) zur Frühdiagnostik der AD, ihre Beziehung zum phiologischen Altern sowie wirksame Strategien zur Behandlung und Vorbeugung der AD bisher unbekannt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alafuzoff K, Iqbal K, Friden R et al. (1978) Histopathologic criteria for progressive dementia disorders. Acta Neuropathol (Berl.) 74: 209–285
Allard M, Signoret JL, Stalleicken D (1988) Alzheimer-Demenz. Springer, Berlin Heidelberg New York Tokyo
Appleyard ME, Smith AD, Berman P et al. (1988) Cholinesterase activities in CSF of patients with senile dementia. Brain 110: 1309–1322
Atack JR, Beal MF, May C et al. (1988a) CSF somatostatin and neuropeptide Y concentrations in aging and in dementia of the Alzheimer Type. Arch Neurol 45: 269–274
Atack JR, May C, Kaye JA et al. (1988b) CSF cholinesterase in aging and in dementia of the Alzheimer type. An Neurol 234: 161–167
Bancher C, Brunner C, Lassmann H et al. (1989) Intraneuronal accumulation of phosphorylated tau precedes the formation of Alzheimer neurofibrillary tangles. Brain res 477: 90–99
Berg L, Miller JPH, Storandt M et al. (1988) Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment. Ann Neurol 23: 477–484
Breitner JCS, Silverman JM, Mohs RC, Davis KL (1988) Familial aggregation in Alzheimer’s disease. Neurology 38: 207–212
Cohen ML, Golde TE, Usiak MF et al. (1988) In situ hybridization of nucleus basalis neurons shows increased β-amyloid RNA in Alzheimer’s disease. Proc Natl Acad Sci USA 85: 1227–1231
Cole G, Dobkins KR, Hansen LA et al. (1988) Decreased levels of protein kinase C in Alzheimer brain. Brain Res 452: 165–174
Coyle JT, Oster-Granit ML, Reeves RH, Gearhart JD (1988) Down syndrome Alzheimer’s disease and the trisomy 16 mouse. TINS 11: 390–394
Coleman PD, Flood DG (1987) Neuron numbers and dentritic extent in normal aging and Alzheimer’s disease. Neurobiol Aging 8: 521–545
Defossez A, Beauvillain JD, Delacourte A (1988) Alzheimer’s disease: A new evidence for common epitopes between microtubules associated protein tau and paired helical filaments. Virchows Arch [A] 413: 141–146
Faber-Langendoen K, Morris JC, Knesevich JW et al. (1988) Aphasia in senile dementia of the Alzheimer Type. Ann Neurol 23: 365–370
Fitch N. Becker R, Heller A (1988) The inheritance of Alzheimer’s disease: A new interpretation. Ann Neurol 23: 14–19
German DC, White CL, Sparkman DR (1987) Alzheimer’s disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience 21: 305–312
Glenner GG (1988) Alzheimer’s disease: Its proteins and genes. Cell 52: 307–308
Hansen LA, DeTeresa R, Davies P, Terry RD (1988) Neocortical morphometry, lesion counts and choline acetyltransferase levels in the age spectrums of Alzheimer’s disease. Neurology 38: 48–57
Hardy J (1988) Molecular biology and Alzheimer’s disease. TINS 11: 293
Hoyer S, Oesterreich K, Wagner O (1988) Glucose metabolism as the site of primary abnormality in early-onset dementia? J Neurol 235: 143–148
Hyman BT, van Hoesen GW, Damasio AR (1987) Alzheimer’s disease: Glutamate depletion in the hippocampal perforant pathway. Ann Neurol 22: 37–40
Jellinger K (1989) Pathologie des alternden Gehirns und der (prä)senilen Demenzen. In: Oesterreich K (Hrsg) Handbuch der Gerontologie, Bd 5: Neurologie. G. Fischer, Stuttgart, S 3–56
Joachim CL, Morris JH, Selkoe DJ (1988) Clinically diagnosed Alzheimer disease: Autopsy results in 150 cases. Ann Neurol 24: 50–56
Johnson KA, Holman L, Mueller SP et al. (1988) Single photon emission computed tomography in Alzheimer’s disease. Arch Neurol 42: 1097–1105
Khachaturian ZS (1985) Diagnosis of Alzheimer’s disease. Arch Neurol 42: 1097–1105
Katzman R (1986) Alzheimer’s disease. N Engl J Med 314: 964–973
Katzman R, Terry RD, DeTeresa R et al. (1988) Clinical, pathologic and neurochemical changes in dementia. Ann Neurol 23: 138–144
Kessler JA (1987) Deficiency of a cholinergic differentiating factor in fibroblasts of Alzheimer disease patients. Ann Neurol 21: 95–98
Love S, Saitoh T, Quijada S et al. (1988) Alz-50, ubiquitin and tau immunoreactivity of neuro-fibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 47: 393–405
Mann DMA (1988) The pathological association between Down syndrome and Alzheimer’s disease. Mech Ageing Dev 43: 99–136
Mann DMA, Marcyniuk B, Yates PO (1988) The progression of the pathological changes of Alzheimer’s disease in frontal and temporal neocortex examined both at biopsy and autopsy. Neuropathol Appl Neurobiol 14: 177–195
McKhann G, Drachman D, Folstein M et al. (1984) Clinical diagnosis of Alzheimer’s disease. Neurology 34: 939–944
Moossy J, Zubenko GS, Martinez AL, Rao GR (1988) Bilateral symmetry of morphologic lesions in Alzheimer’s disease. Arch Neurol 45: 251–254
Muma NA, Troncoso JC, Hoffman PN et al. (1988) Aluminium neurotoxicity: Altered expression of cytoskeletal genes. Mol Brain Res 3: 115–122
Nukina N, Kosik KS, Selkoe DJ (1988) The monoclonal antibody Alz 50 recognizes tau proteins in Alzheimer disease brain. Neurosci Lett 87: 240
Palmer AM, Stratman PC, Procter AW, Bowen DM (1988) Possible neurotransmitter basis of behavioral changes in Alzheimer’s disease. Ann Neurol 23: 616–620
Pettegrew JW, Moossy HJ, Withers G et al. (1988) P nuclear magnetic resonance study of the brain in Alzheimer’s disease. J Neuropathol Exp Neurol 47: 235–248
Powers JM, Skeen JT (1988) Ultrastructural heterogeneity in cerebral amyloid of Alzheimer’s disease. Acta Neuropathol (Berl) 77: 168–174
Probst A, Anderton BH, Brion JP, Ulrich J (1988) Senile plaque neurites fail to demonstrate anti-PHF and anti-MAP tau immunoreactive proteins in the absence of neurofibrillary tangles. Acta Neuropathol (Berl) 77: 430–436
Procter AW, Palmer AM, Francis PT et al. (1988) Evidence for glutamatergic denervation and possible abnormal metabolism in Alzheimer’s disease. J Neurochem 50: 790–802
Prohovnik I, Mayeux R, Sackeim HA et al. (1988) Cerebral perfusion as a diagnostic marker of early Alzheimer disease. Neurology 38: 931–937
Rae-Grant A, Blume W, Lau C et al. (1987) The electroencephalogram in Alzheimer type dementia. Arch eurol 44: 50–54
Reinikainin KJ, Paljärvi L, Halonen T et al. (1988) Dopaminergic system and monoamine oxidase B activity in Alzheimer’s disease. Neurobiol Aging 9: 245–252
Reinikainen KJ, Rieekkinen PJ, Paljärvi L et al. (1988) Cholinergic deficit in Alzheimer’s disease: A study based on CSF and autopsy data. Neurochem Res 13: 135–146
Riede WH, Metter EJ (1987) Cognitive and brain imaging measures of Alzheimer’s disease. Neurobiol Aging 9: 69–86
Saper CB, Rye DB, Davies P (1988) Alz-50 immunoreactive staining in normal and Alzheimer brain. Ann Neurol (Abstr) 24: 124
Schoenberg BS, Kokmen E, Okazaki H (1987) Alzheimers disease and other dementing illnesses in a defined US population. Ann Neurol 22: 724–729
Schreiter U, Bieder S (1988) Die Alzheimersche Krankheit; Befunde und Hypothesen. Nervenarzt 59: 73–84
Schmidt ML, Gur RE, Gur BC, Trojanowski JQ (1988) Intraneuronal and extracellular neurofibrillary tangles exhibit mutually exclusive cytoskeletal antigens. Ann Neurol 23: 184–189
Sheridan PH, Sato S, Fosten N et al. (1988) Relation of EEG alpha background to parietal lobe function in Alzheimers disease as measured by PET and psychometry. Neurology 38: 747–750
Sims NR, Finegan JM, Blass JP et al. (12987) Mitochondrial function in brain tissue in primary degenerative dementias. Brain Res 436: 30–38
Smith G (1988) Animal models of Alzheimer’s disease: Experimental cholinergic denervation. Brain Res Rev 13: 103–118
Struble EF, Powers RE, Casanava MF et al. (1988) Neuropeptidergic systems in plaques of Alzheimer’s disease. J Neuropathol Exp Neurol 46: 567–584
Tanzi RE, Gusella JF, Watkins PC et al. (1987) Amyloid β-proteins gene cDNA, βRNA distribution and genetic linkage. Science 235: 880–884
Terry RD, Hansen LA, DeTeresa H, Katzman R (1987) Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 46: 262–268
Tierney MC, Fisher RH, Lerwis AJ et al. (1988) The NINDCS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease. Neurology 38: 359–364
Ulrich J, Probst A, Langui D et al. (1987) Cytoskeletal immunohistochemistry of Alzheimer’s disease and related diseases. Pathol Immunopathol Res 6: 273–283
Vinters HV, Partridge WM, Yang J (1988) Immunohistochemistry of Alzheimer’s disease and related diseases. Human Pathol 19: 214–222
Wade JP, Mirsen TH, Hatchinski VC et al. (1987) The clinical diagnosis of Alzheimer’s disease. Arch Neurol 44: 24–29
Wegiel J, Wisniewski JM, Wang KC et al. (1988) The role of microglia in plaque formation in Alzheimer’s disease. J Neuropathol Exp Neurol 47: 338
Wilcock Gk (1988) Alzheimer’s disease — current issues. Quart J Med 66: 117–124
Wischik CM, Novak M, Thegersen PC et al. (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer’s disease. Proc Natl Acad Sci USA 85: 4506–5411
Wolozin B, Davies P (1987) Alzheimer-related neuronal protein A68: Specificity and distribution. Ann Neurol 22: 521–526
Yamaguchi H, Hirai S, Morimatsu M et al. (1988) A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by β-protein immunostaining. Acta Neuropathol (Berl) 77: 113–119
Zubenko GS, Moossy J, Hanin I et al. (1988) Bilateral symmetry of cholinergic deficits in Alzheimer’s disease. Arch Neurol 545: 255–259
Zweig RM, Ross CA, Hedreen JC et al. (1988) The neuropathology of aminergic nuclei in Alzheimer’s disease. Ann Neurol 24: 233–242
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jellinger, K. (1989). Die Alzheimer-Krankheit. In: Fischer, PA., Baas, H., Enzensberger, W. (eds) Verhandlungen der Deutschen Gesellschaft für Neurologie. Verhandlungen der Deutschen Gesellschaft für Neurologie, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83771-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-83771-5_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-51091-8
Online ISBN: 978-3-642-83771-5
eBook Packages: Springer Book Archive